The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
April 30th 2025
Biomarker testing transforms non-small cell lung cancer treatment, enhancing outcomes through targeted therapies and next-generation sequencing for better patient care.
Flu Shot May Assist In Heart Bypass Recovery
November 15th 2019Receiving a flu shot before a heart bypass surgery can stop inflammation throughout the body and possibly lead to a healthier recovery, according to a preliminary study presented at the American Heart Association’s Scientific Sessions in Philadelphia, Pennsylvania.
Read More
New, Online Resource Designed to Assist Pharmacists With CBD Products
November 13th 2019The online resource features CBD products that have been tested for concentrations of all cannabinoids, including CBD and tetrahydrocannabinol (THC), by an independent, third-party lab, as well as experts that pharmacists can contact with questions regarding buying, selling, and marketing.
Read More
Injectable Hormone Tesamorelin Reduces Liver Fibrosis in Patients with HIV
November 13th 2019The injectable hormone tesamorelin was found to reduce liver fat and prevent liver fibrosis or scarring in people living with HIV, according to researchers and the National Institutes of Health and the National Institute of Allergy and Infectious Disease (NIAD).
Read More
Study: Affordable Care Act Improved Insurance Coverage for People With Both Cancer, HIV
November 13th 2019A recent study published in CANCER indicates that for patients with both HIV and cancer, implementation of the Patient Protection and Affordable Care Act (ACA) improved insurance coverage, both in states that expanded Medicaid coverage and in states that did not.1
Read More
FDA: Lower Levels of NDMA in Ranitidine than Previously Reported
November 4th 2019Although the levels of NDMA that was found through FDA testing are much lower than the levels that a few third-party investigators claimed, the report indicated that these levels exceed what the FDA considers acceptable for these medicines.
Read More